Is it safe to deliver SBRT with concurrent immunotherapy to head and neck sites of progressive metastatic disease?
What doses and constraints do you use?
1 Answer
Mednet Member
Radiation Oncology · Cleveland Clinic
Answered on
Yes, have done this many times. Constraints are hard to come by. If it is reirradiation, RTOG 3507 provides guidance, if it is never radiated you have even more leeway.
Join for free or sign in to see the full answer